Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma
- 30 April 1986
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 22 (1) , 15-23
- https://doi.org/10.1007/bf00205711
Abstract
This study investigates the nature and specificity of cytotoxic T lymphocytes (CTL) in patients with melanoma which are able to kill autologous melanoma cells. Interleukin 2 (IL2)-dependent T cell clones from two melanoma patients and a normal subject were generated in mixed lymphocyte cultures (MLC) or mixed lymphocyte tumor cell cultures (MLTC) and propagated for prolonged periods in tissue culture. Analysis of their phenotype by a wide range of monoclonal antibodies (M.Abs) revealed two main phenotypes which depended on whether they expressed Fc receptors detected by Leu 11 M.Abs or not. Leu 11− T cells (referred to as Type 1) were inhibited by M.Abs to T3, T8, and a common HLA, ABC antigen. Conversely Leu 11+ T cells (referred to as Type 2) were inhibited by M.Ab to Leu 11 but not by M.Ab to T3, T8 and the HLA, ABC antigen. Subtypes among Type 1 cells were recognized which depended on their specificity. The most restricted were CTL [Type 1(a)] clones generated only in MLTC which recognized the autologous melanoma cell plus 1 of 11 other melanoma target cells. Type 1(b) CTL clones recognized a larger proportion (approximately 50%) of the melanoma cells. A third category [Type 1(c)] recognized antigens on melanoma cells shared with that on the EBV-transformed B cells used as stimulators in the MLC. Type 2 CTL clones had broad specificity to melanoma and nonmelanoma cells, characteristic of that described for lymphokine activated killer (LAK) cells. The latter were MHC unrestricted but further studies are required to clarify whether the Type 1 CTL clones are MHC restricted or not. The CTL activity of all clones was inhibited by M.Ab to the sheep red blood cell receptor and to the T10 antigens. It is suggested that recognition of these different types of CTL clones may assist future studies on the immune response against melanoma and the nature of antigens recognized by CTL.Keywords
This publication has 32 references indexed in Scilit:
- Role of IA-Like and THY-1 Antigens in Bone Marrow EngraftmentTransplantation, 1986
- Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in cultureNature, 1984
- Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.The Journal of Immunology, 1984
- Clonal analysis of cytotoxic T cell response against human melanoma.The Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cellsThe Journal of Experimental Medicine, 1983
- Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.The Journal of Immunology, 1983
- Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2International Journal of Cancer, 1982
- Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.The Journal of Immunology, 1981
- Continuous culture of T cells cytotoxic for autologous human leukaemia cellsNature, 1979
- Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. I. Complete regression of virus‐induced transformation in cultures of seropositive donor leukocytesInternational Journal of Cancer, 1978